Related Experiment Video
Updated: Aug 15, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
[Mood disorders in perimenopausal women: hormone replacement or antidepressant therapy?]
Gilles Bertschy1, Dominique De Ziegler, Francesco Bianchi-Demicheli
1Service de psychiatrie adulte, Département de psychiatrie, HUG, 1211 Genève 14.
Abstract:
Perimenopause (and not the entire postmenopausal period) is a period at risk for depression. Menopause is a psychosocial and physiologic reality whose neurobiological aspects are often under-estimated. Various disturbances, such as hot flushes and, at least in part, depressive disorders, are related to this neurobiological dimension. When the depression is minor, hormone replacement therapy may be an adequate treatment. Keeping in mind the complex interactions that may occur between endogenous and exogenous progestins at the neuronal level, we would recommend a physiologic replacement using transdermal estradiol and vaginal progesterone. When the depression is major, present data do not support the possibility of using hormone replacement therapy instead of antidepressants.
Related Concept Videos
Menopause
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Drug Therapy
Antianxiety Medications
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Depressive Disorders: MDD and Dysthymia
